Can propranolol (beta-blocker) be administered through a Nasogastric Tube (NGT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration of Propranolol Through a Nasogastric Tube

Yes, propranolol can be administered through a nasogastric tube (NGT) when appropriate administration techniques are followed.

Proper Administration Technique

Pre-Administration Steps

  • Verify NGT placement before medication administration
  • Flush the tube with at least 30 mL of water to clear any residual formula 1
  • Temporarily stop enteral feeding for medication administration

Administration Method

  1. For immediate-release propranolol tablets:

    • Crush tablets thoroughly until they become a fine powder
    • Mix with 15-30 mL of water
    • Ensure complete dissolution before administration to prevent tube occlusion 2
  2. For liquid formulations (if available):

    • Administer directly through the tube (preferred option)
    • Do not mix with other medications 2
  3. Use appropriate ENFit syringes that comply with ISO 80369-3 standards to avoid misconnection errors 1

Post-Administration Steps

  • Flush the tube with at least 30 mL of water after administration to prevent tube occlusion and ensure complete medication delivery 1
  • Resume enteral feeding as appropriate

Important Considerations

Formulation Considerations

  • Do not use sustained-release or controlled-release formulations of propranolol through NGT as crushing these would alter drug release patterns and potentially cause toxicity 3
  • Immediate-release propranolol tablets are appropriate for NGT administration when properly crushed and suspended 2
  • Liquid formulations are preferred when available as they eliminate the need for crushing and reduce the risk of tube occlusion 4

Clinical Monitoring

  • Monitor for expected therapeutic effects and potential adverse effects including:
    • Bradycardia
    • Hypotension
    • Sleep disturbances
    • Bronchial irritation 1

Potential Complications

  • Tube occlusion if medication is not properly crushed or dissolved
  • Reduced drug efficacy if administered with enteral formula (consider pausing feeds) 1
  • Risk of aspiration during NGT placement or medication administration 5

Special Considerations

  • Bioavailability may be affected when administering medications through NGT compared to oral administration 4
  • Consider consulting with a pharmacist before crushing and administering medications through feeding tubes 2
  • For patients with significant GI tract resections, drug absorption may be compromised 1

Common Pitfalls to Avoid

  • Never crush extended-release or enteric-coated formulations of propranolol
  • Avoid mixing propranolol with enteral formula directly
  • Do not shake low-dose ENFit tip syringes to remove drug residue as this can affect dose accuracy 1
  • Avoid administering propranolol distal to the stomach if possible, as this may reduce absorption 1

Following these guidelines will help ensure safe and effective administration of propranolol through a nasogastric tube while minimizing risks of complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Administration of Medications through a Gastrostomy Tube

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Therapeutic concerns when oral medications are administered nasogastrically.

Journal of clinical pharmacy and therapeutics, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.